Published in
Elsevier, EClinicalMedicine, (64), p. 102249, 2023
DOI: 10.1016/j.eclinm.2023.102249
Links
Tools
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study
Journal article published in 2023 by
Zhigang Liu 
,
James L. Alexander ,
Kaixing Le,
Xin Zhou,
Hajir Ibraheim,
Sulak Anandabaskaran,
Aamir Saifuddin,
Kathy Weitung Lin,
Leon R. McFarlane,
Laura Constable,
Rocio Castro Seoane,
Nikhil Anand ,
Claire Bewshea ,
Rachel Nice,
Andrea D'Mello
and other authors.
,
James L. Alexander ,
Kaixing Le,
Xin Zhou,
Hajir Ibraheim,
Sulak Anandabaskaran,
Aamir Saifuddin,
Kathy Weitung Lin,
Leon R. McFarlane,
Laura Constable,
Rocio Castro Seoane,
Nikhil Anand ,
Claire Bewshea ,
Rachel Nice,
Andrea D'Mello
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 